Osaka, Japan, April 5, 2024 - Ono Pharmaceutical Co., Ltd. announced that it has decided changes of the Board of Directors, Audit & Supervisory Board Members and Corporate Officers at the.
ONO PHARMA Announces Enrollment Is Complete For The First Arm Of The PROSPECT Study Of Tirabrutinib In U S Patients With Relapsed Or Refractory PCNSL menafn.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from menafn.com Daily Mail and Mail on Sunday newspapers.
/PRNewswire/ ONO Pharmaceuticals, Co., Ltd. today announced it has completed target patient enrollment of the first arm (Part A) of the PROSPECT Study, a.
/PRNewswire/ Caris Life Sciences®, a molecular science company developing and delivering technologies to revolutionize healthcare, and Ono Pharmaceutical Co..
Caris Life Sciences and Ono Pharmaceutical Announce Strategic Collaboration Leveraging Caris' Novel, Blood-Based cNAS Molecular Profiling Assay Across Several Ono Clinical Studies - read this article along with other careers information, tips and advice on BioSpace